register free | resend password

Pressemitteilungen zu dem Thema novartis


Unterkategorien

PresseMitteilungen zu dem Schlagwort novartis


Novartis wins the SAMS Award 2018 for Software Asset Management

Aachen, Germany, March 5, 2018 - Novartis Pharma AG was honored with a SAMS Award in the "Overall Project/Strategy" category at the SAM Strategies Conference in Berlin last week. Their "Top 100 Cost Reduction Initiative" project aimed to save significant money, gain software compliance transparency, and improve processes in software procurement and software usage. The IT and Procurement department worked closely together to examine 1,200 software vendors and determined that ...


05.03.2018

Novartis wins 1st place at the SAMS Europe Award 2017 with "Cloud SAM for Salesforce"

License Control for Salesforce from Aspera enables cloud cost optimization. Aachen/Berlin, Germany, September 26, 2017 - Last night in Berlin, Novartis, the Swiss pharmaceutical group and a client of Aspera, was awarded 1st place in the "Tool/Software" category for developing an innovative license-management solution for optimizing Salesforce licenses. Novartis AG is one of the largest pharmaceutical companies in the world, with around $49 billion in sales in 2016. The goal of the &q ...


26.09.2017

ONL Therapeutics Closes Series A Financing to Support Development of Novel Retinal Cell Protection Platform for Treatment of Ocular Diseases

ANN ARBOR, MI -- (Marketwired) -- 05/17/17 -- ONL Therapeutics, Inc., a biopharmaceutical company developing novel therapies for preserving sight in a range of retinal diseases, today announced that it has closed a $4.25 million Series A round of fundraising. Proceeds from the fundraising combined with the recently announced $1 million grant from the National Eye Institute, will primarily be used to finalize preclinical development of ONL1204, the company''s lead therapeutic candidate ...


17.05.2017

Contact Lenses Global and United States Market Outlook Covering Status and Forecast during 2017-2022

Albany, New York, April 8, 2017: As per a recent research report, the constant rise in the world’s population that suffers from a variety of eye disorders has emerged as the primary growth driver of the contact lens market worldwide. Also, the easy availability of colored, disposable and inexpensive varieties of contact lenses have led to the immense rise in their usage as fashion accessories, due to this, the global market of Contact Lenses has gained a significant value (million USD) in the ye ...


08.04.2017

Beyond the Smoke Stacks: Texas Ropes in $4 Billion Pharma-Bio Investment, an Industrial Info News Alert

SUGAR LAND, TX -- (Marketwired) -- 01/17/17 -- Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- When many people hear the word "Texas," it evokes a number of clichés, typically a mélange of cattle, chemical plants, oil and gas drilling, and rodeos. But that sells the state short, for beyond the smoke stacks of the hundreds of the state''s chemical processing plants and refineries are a surprising number of .For details, , or browse other breaking ...


17.01.2017

Novartis Restructuring Continues as Pharmaceuticals Division Splits, Along With Pharma CEO, an Industrial Info News Alert

SUGAR LAND, TX -- (Marketwired) -- 05/27/16 -- Reported by Annette Kreuger, Industrial Info Resources, Incorporated (Sugar Land, Texas) -- One of the ''s top three drug makers, Swiss-based Novartis International AG (NYSE:NVS) (Basel, has restructured its pharmaceuticals division by creating two business units -- Novartis Pharmaceuticals and Novartis Oncology. Coinciding with the organizational split, the division head and chief executive officer of the company''s Pharmaceuti ...


27.05.2016

Bingo to Biotech: the Pharma-Bio Industry Breathes New Life Into Old Buildings Across the World, an Industrial Info News Alert

SUGAR LAND, TX -- (Marketwired) -- 05/17/16 -- Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- The very core of the is ingenuity and innovation. And, those dual philosophies spread beyond the discovery and production of the drugs and medical devices, to the facilities within which those tasks are carried out. Often, in the most unlikely of places.For details, , or browse other breaking industrial news stories at .Industrial Info Resources (IIR), with global headqu ...


17.05.2016

Who''s on First? Top 10 Global Pharmaceutical Companies Raked in Over $361 Billion in 2015 Sales, an Industrial Info News Alert

SUGAR LAND, TX -- (Marketwired) -- 04/04/16 -- Researched by Industrial Info Resources (Sugar Land, Texas) -- It is a rarified air up at the top, but not exactly lonely, as the world''s mightiest companies jockey for space to be number one. A look at just the top 10 (as listed in the 2016 Pharmaceutical & Biotech Outlook) reveals over $361 billion in combined 2015 pharma sales revenue. While some of the players are familiar, others are comparative upstarts, who charged up the hil ...


04.04.2016

Almost the Same, but Not Quite... Biosimilars Market Expected to Hit $25 Billion by 2020, an Industrial Info News Alert

SUGARLAND, TX -- (Marketwired) -- 03/29/16 -- Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- Generics have long been the bane of Big Pharma. Waiting in the wings until a drug''s patent expires, low-cost copycats then flood into the market as watch their profits take a dive. The market was once limited to traditional pharmaceutical products, but this is no longer true as a growing number of biopharmaceuticals, or biologics, are headed for their own paten ...


29.03.2016

Investment Professionals Pick Switzerland''s Top CEOs, CFOs & IR Professionals

NEW YORK, NY -- (Marketwired) -- 04/21/15 -- Institutional Investor has announced the winners of the , II''s annual ranking of the region''s corporate leaders. II asked portfolio managers, buy-side analysts and sell-side research professionals to name the best CEOs, CFOs and investor relations professionals at the European companies they cover. Listed below are the CEOs and CFOs who lead companies headquartered in Switzerland, who rank First, Second or Third in their sector. ...


21.04.2015

New England Has $9 Billion Worth of Reasons to Embrace the Pharmaceutical-Biotech Industry, an Industrial Info News Alert

SUGAR LAND, TX -- (Marketwired) -- 07/24/13 -- Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- North America has nearly 1,300 active Pharmaceutical-Biotech capital and maintenance projects with a total investment value (TIV) of $57 billion. According to a recent analysis of Industrial Info's database, the region reigns in the top spot with a $9 billion slice of that spending.Other companies featured: (NASDAQ:VRTX), (NYSE:NVS)For details, view the entire ar ...


24.07.2013

Qu Biologics Appoints Former Novartis President Mr. Robert Pelzer to its Board of Directors

VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 06/13/13 -- , a biopharmaceutical company developing (SSIs) that aim to "reboot" the body's immune system, is pleased to welcome Mr. Robert Pelzer to the company's Board of Directors. Mr. Pelzer was most recently President of Novartis Corporation based in New York, NY."It is an honour to welcome Bob Pelzer, a distinguished and accomplished leader in the pharmaceutical industry, to Qu Biologics' Board of Directors,&qu ...


13.06.2013

Qu Biologics Appoints Former Novartis President Mr. Robert Pelzer to its Board of Directors

VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 06/13/13 -- , a biopharmaceutical company developing (SSIs) that aim to "reboot" the body's immune system, is pleased to welcome Mr. Robert Pelzer to the company's Board of Directors. Mr. Pelzer was most recently President of Novartis Corporation based in New York, NY."It is an honour to welcome Bob Pelzer, a distinguished and accomplished leader in the pharmaceutical industry, to Qu Biologics' Board of Directors,&qu ...


13.06.2013

INTERPHEX 2013: It's a Wrap on Pharma's Biggest Conference of the Year, an Industrial Info News Alert

SUGAR LAND, TX -- (Marketwired) -- 04/30/13 -- Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- It was all about the last week at the INTERPHEX 2013, which was held April 23-25 at the Javits Center in New York. With exhibitors at an all-time high, the convention hall floor was abuzz with news of innovative new products and services. Ultimately, the reason for the elaborate exhibits and informative breakout sessions was the successful construction, validation and op ...


30.04.2013

Got BIO? Better Get It! BIO 2013 Report Credits Industry With 1.6 Million High-Income U.S. Jobs, an Industrial Info News Alert

CHICAGO. IL -- (Marketwired) -- 04/26/13 -- Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- Amidst all of the activity as BIO 2013 continued (McCormick Place in Chicago, April 22 through 25, 2013), an important report was released by the Industry Organization (BIO) (Washington, D.C.) on Tuesday April 23, 2013. The "Bioscience Economic Development: Legislative Priorities, Best Practices, and Return On Investment" elaborates on how important the industry i ...


26.04.2013

Pharma-Biotech Industry Invests More Than $12 Billion in 2012 North American Project Starts, an Industrial Info News Alert

SUGAR LAND, TX -- (Marketwire) -- 12/18/12 -- Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- As the last moments of 2012 run their course, it is a good time to take a look at the 's capital and maintenance (MRO) project activity for the year. In January, the industry had a whopping $17 billion worth of projects set to launch construction in 2012. Almost a year later, that number has taken a dip to just more than $12 billion worth of projects that actually mad ...


18.12.2012

Seegene to Participate in High Profile Panel on Companion Diagnostics at BIO-Europe 2012

GAITHERSBURG, MD and SEOUL, KOREA -- (Marketwire) -- 11/07/12 -- Seegene Inc., (KOSDAQ: 096530) today announced that the company's Executive Vice President, David L. Dolinger, Ph.D., will participate in a high profile panel on companion diagnostics titled "" at , on November 12 in Hamburg, Germany.Dolinger will be joined by fellow panelists Guy Greiveldinger, Director, BD&L and M&A, Novartis; Bruce Jordan, Senior International Product Manager, Roche Diagnostics; David de ...


07.11.2012

Industry Without Borders: Pharmaceutical-Biotech Capital Investment Leaps Around the Globe, an Industrial Info News Alert

SUGAR LAND, TX -- (Marketwire) -- 10/17/12 -- Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- There is no denying that the is becoming global to its core, an aspect firmly underscored as investments rise for new facility builds and expansions around the world. In just the past few weeks, there has been a spate of industry announcements, illustrating the continued spending impact of the industry reaching far beyond North American shores.Other companies featured: ( ...


17.10.2012

Pharma-Bio Industry Sees $6.8 Billion in Capital Investments From 214 Construction Projects Launched in First-Half 2012, an Industrial Info News Alert

SUGAR LAND, TX -- (Marketwire) -- 07/06/12 -- Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- As the third quarter of 2012 begins, a look back over the past six months reveals that the has kicked off construction on nearly $7 billion worth of capital and MRO projects. The 214 projects are spread through North America and carry an average total investment value (TIV) of $32 million.Other companies featured: (NYSE:ABT), (NYSE:STJ)For details, view the entire artic ...


06.07.2012

Vaccines' Allure Remains Solid for Pharma, Attracting $2.5 Billion in North American Capital Investment, an Industrial Info News Alert

SUGAR LAND, TX -- (Marketwire) -- 04/25/12 -- Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- Vaccines continue to attract the drug industry for the same reasons as they always have. The vaccines sector is a darling in that there always seems to be some government funding involved. That particular flow has been staunched a bit, but this is not expected to last, as the clamor for vaccines never really dissipates. By the end of 2012, the global vaccine market is expe ...


25.04.2012

Documents Uncovered by Judicial Watch Detail Big Pharma Campaign Access to Democratic Governors During 2012 National Governors Association Meeting

WASHINGTON, DC -- (Marketwire) -- 03/28/12 -- , the public interest group that investigates and prosecutes government corruption, announced today that it has detailing private events involving Democratic governors during the February 2012 winter meeting of the (NGA). These events were widely attended by unions, drug companies and other health concerns.The events included a Pfizer-sponsored evening reception and dinner for members of the Democratic Governors Association (DGA) Chairman's ...


28.03.2012

New England Clear Leader as 1Q12 Pharma-Biotech Construction Starts Top $2.8 Billion, an Industrial Info News Alert

SUGAR LAND, TX -- (Marketwire) -- 03/09/12 -- Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- It is lonely at the top, when considering North America in terms of capital and maintenance (MRO) investment. Out of $2.7 billion in scheduled North American Pharma-Bio project starts for the first quarter of 2012, jumped to the top of the heap by claiming more than $1 billion of the total for only nine projects, out of a total of 106. The region can thank Massachusetts ...


09.03.2012

Pharma-Biotech Capital Construction Investment Snapshot: 2012 North American Project Starts Top $16 Billion, an Industrial Info News Alert

SUGAR LAND, TX -- (Marketwire) -- 02/29/12 -- Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- Barely two months into the new year, it is time to buckle up and enjoy the wild ride known as the . In January 2012, the industry as a whole had more than $17 billion in capital and maintenance projects scheduled to kick off this year. A scant month later, that total has dropped to slightly more than $16 billion. Thanks in no small part to the Obama administration's ...


29.02.2012

Flu Season Gives Big Pharma $3.5 Billion Shot in Fiscal Arm, an Industrial Info News Alert

SUGAR LAND, TX -- (Marketwire) -- 11/18/11 -- Researched by Industrial Info Resources (Sugar Land, Texas) -- The end of the year brings the holiday season and festivities, but it also marks the start of the influenza season and another round of flu shots. Worldwide, seasonal influenza kills an estimated 250,000 to 500,000 people each year. Tens of thousands of Americans die in a typical flu season. Governments and pharmaceutical companies have been preparing for flu season since the beginning o ...


18.11.2011

Annual Survey Finds That Leading Pharma Companies No Longer See Sales as the Only Measure of Success

NEW YORK, NY -- (Marketwire) -- 10/25/11 -- , a leading global, evidence-based decision support partner to the world's leading pharmaceutical, biotech, device and diagnostic companies, recently delivered the anticipated 2011 results of its annual Stakeholder Effectiveness survey, which revealed that over two-thirds respondents from leading companies in the pharmaceutical sector think that customer retention is a key performance measure.These results show a dramatic shift since the initial ...


25.10.2011



All members: 9 353
Register today: 4
Register yesterday: 2
Members online: 0
Guests online: 57


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.